By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087



Company News
Aerie (AERI) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Business Update 3/8/2017 7:29:20 AM
Aerie (AERI) Announces Resubmission Of NDA For Rhopressa (Netarsudil Ophthalmic Solution) 0.02% 3/1/2017 10:56:53 AM
Aerie (AERI) To Announce Fourth Quarter And Year End 2016 Financial Results And Host Conference Call On Tuesday, March 7, 2017 2/27/2017 8:58:06 AM
Aerie (AERI) Announces Appointment Of Barry Ivin As Site Director Of New Manufacturing Plant In Ireland 2/6/2017 7:42:06 AM
Aerie (AERI) Announces Appointment Of Huan Sheng, M.D., Ph.D., As Director Clinical Research And Drug Safety 2/6/2017 7:35:41 AM
Aerie (AERI) Release: Company Announces Appointment Of Kristine Erickson, O.D., Ph.D., As Vice President Clinical Research 1/23/2017 8:13:04 AM
SoCal's Aerie (AERI) to Create 50 New Jobs in Ireland 1/13/2017 6:34:46 AM
Aerie (AERI) Enters Into Lease Agreement For New Manufacturing Plant In Ireland 1/9/2017 1:04:03 PM
Another Delay, Aerie (AERI) Now Expects to Resubmit Rhopressa NDA Filing in Q1 2017 12/27/2016 7:21:16 AM
Aerie (AERI) Announces Appointment Of Judith J. Robertson As Chief Commercial Officer 12/19/2016 9:51:38 AM